Wilson's disease (hepatolenticular degeneration)

Area of Science:

• Genetics and Metabolism

Background:

• Wilson's disease (hepatolenticular degeneration) is a rare, inherited disorder affecting copper metabolism, primarily impacting young individuals.
• It is inherited in an autosomal recessive pattern, leading to excess copper accumulation in organs like the liver, brain, and cornea.

Observation:

• Ocular findings, particularly Kayser-Fleischer rings and sunflower cataracts, are key diagnostic indicators.
• Hepatic involvement often manifests in childhood, while neurological deficits typically appear later.

Findings:

• The exact pathogenesis and genetic defect remain unclear, though theories involve impaired ceruloplasmin synthesis or abnormal copper-binding proteins.
• Diagnosis relies on clinical presentation, Kayser-Fleischer rings, and biochemical tests including serum ceruloplasmin, urinary copper, and hepatic copper concentration.

Implications:

• Treatment involves copper chelation therapy (penicillamine) and dietary copper restriction, leading to improvement if irreversible damage hasn't occurred.
• Lifelong maintenance therapy is essential for maintaining a negative copper balance and preventing relapse.